AdjuTec Pharma leads €2.2M Eurostars project to combat deadly lung infections
Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen
•Barnspar: Bästa kontot, sparform och strategi för framtiden – så börjar du barnspara

Pressmeddelande

AdjuTec Pharma leads €2.2M Eurostars project to combat deadly lung infections

MFN Publicerad: 28 Aug 08:54

AdjuTec Pharma has signed a €2.2 million Eurostars consortium agreement, spearheading an international effort to combat multidrug-resistant lung infections. The three-year project will unite four European partners in the search for effective new antibiotic combinations, leveraging AdjuTec’s resistance-breaking technology. BioStock reached out to CEO Jethro Holter and COO Bjørn Klem for comments.

Read the full interview at biostock.se:

https://biostock.se/en/2025/08/adjutec-pharma-leads-e2-2m-eurostars-project-to-combat-deadly-lung-infections/
 
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter 
Follow BioStock on social media: LinkedIn and Facebook!  
 
About BioStock 
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.  
BioStock – Connecting Innovation & Capital. 

Läses av andra just nu

Senaste nytt